Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Akimasa Sanagawa, Yuji Hotta, Tomoya Kataoka, Yasuhiro Maeda, Masahiro Kondo, Yoshihiro Kawade, Yoshihiro Ogawa, Ryohei Nishikawa, Masahiro Tohkin & Kazunori Kimura. (2018)
Hepatitis B infection reported with cancer chemotherapy: analyzing the
US FDA
Adverse Event Reporting System
. Cancer Medicine 7:6, pages 2269-2279.
Crossref
Crossref
Mohit Mittal & Ke-Qin Hu. (2017) Clinical Implications and Management of Chronic Occult Hepatitis B Virus Infection. Current Hepatology Reports 16:2, pages 90-96.
Crossref
Crossref
C. Sagnelli, M. Macera, M. Pisaturo, R. Zampino, M. Coppola & E. Sagnelli. (2016) Occult HBV infection in the oncohematological setting. Infection 44:5, pages 575-582.
Crossref
Crossref
Manoochehr Makvandi. (2016) Update on occult hepatitis B virus infection. World Journal of Gastroenterology 22:39, pages 8720.
Crossref
Crossref
Shingo Nakamoto, Tatsuo Kanda, Chiaki Nakaseko, Emiko Sakaida, Chikako Ohwada, Masahiro Takeuchi, Yusuke Takeda, Naoya Mimura, Tohru Iseki, Shuang Wu, Makoto Arai, Fumio Imazeki, Kengo Saito, Hiroshi Shirasawa & Osamu Yokosuka. (2014) Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment. International Journal of Molecular Sciences 15:11, pages 21455-21467.
Crossref
Crossref
Evangelista Sagnelli. (2014) Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World Journal of Hepatology 6:6, pages 384.
Crossref
Crossref
Diana Pomakova & Brahm H. Segal. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients
485
511
.
Gilda Tonziello, Marintonietta Pisaturo, Antonello Sica, Maria Giovanna Ferrara, Caterina Sagnelli, Giuseppe Pasquale, Evangelista Sagnelli, Salvatore Guastafierro & Nicola Coppola. (2012) Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma. Infection 41:1, pages 225-229.
Crossref
Crossref
M. Tomblyn, M. Chen, M. Kukreja, M.D. Aljurf, F. Al Mohareb, B.J. Bolwell, J.‐Y. Cahn, M.H. Carabasi, R.P. Gale, R.E. Gress, V. Gupta, G.A. Hale, P. Ljungman, R.T. Maziarz, J. Storek, J.R. Wingard, J.‐A.H. Young, M.M. Horowitz & K.K. Ballen. (2012)
No increased mortality from donor or recipient hepatitis
B
‐ and/or hepatitis
C
‐positive serostatus after related‐donor allogeneic hematopoietic cell transplantation
. Transplant Infectious Disease 14:5, pages 468-478.
Crossref
Crossref
Florian Weissinger, Holger W. Auner, Hartmut Bertz, Dieter Buchheidt, Oliver A. Cornely, Gerlinde Egerer, Werner Heinz, Meinolf Karthaus, Michael Kiehl, William Krüger, Olaf Penack, Stefan Reuter, Markus Ruhnke, Michael Sandherr, Hans-Jürgen Salwender, Andrew J. Ullmann, Dirk T. Waldschmidt & Hans H. Wolf. (2012) Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology 91:8, pages 1161-1174.
Crossref
Crossref
L. Milazzo, M. Corbellino, A. Foschi, V. Micheli, A. Dodero, A. Mazzocchi, V. Montefusco, G. Zehender & S. Antinori. (2011) Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy. Transplant Infectious Disease 14:1, pages 95-98.
Crossref
Crossref
Silvia Park, Kihyun Kim, Dong Hwan Kim, Jun Ho Jang, Seok Jin Kim, Won Seog Kim, Chul Won Jung & Kwang Cheol Koh. (2011) Changes of Hepatitis B Virus Serologic Status after Allogeneic Hematopoietic Stem Cell Transplantation and Impact of Donor Immunity on Hepatitis B Virus. Biology of Blood and Marrow Transplantation 17:11, pages 1630-1637.
Crossref
Crossref
Nicola Coppola, Gilda Tonziello, Mariantonietta Pisaturo, Vincenzo Messina, Salvatore Guastafierro, Marco Fiore, Valentina Iodice, Caterina Sagnelli, Maria Stanzione, Nicolina Capoluongo, Giuseppe Pasquale & Evangelista Sagnelli. (2011) Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. Journal of Medical Virology 83:11, pages 1909-1916.
Crossref
Crossref
M Viganò, C Vener, P Lampertico, C Annaloro, C Pichoud, F Zoulim, F Facchetti, F Poli, M Scalamogna, G Lambertenghi Deliliers & M Colombo. (2010) Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT. Bone Marrow Transplantation 46:1, pages 125-131.
Crossref
Crossref
Raymond Liang. (2009) How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood 113:14, pages 3147-3153.
Crossref
Crossref
Bo Ran KwonJung Ha MokJung Ho BaeHee Yun SeolYoung Mi SeolMoo-Kon SongYoung Jin ChoiHo Jin ShinJoo Seop ChungGoon Jae Cho. (2008) Reverse Seroconversion of Hepatitis B following Allogenic Hematopoietic Stem Cell Transplantation from a Hepatitis Immune Donor in a Multiple Myeloma Patient. The Korean Journal of Hematology 43:2, pages 122.
Crossref
Crossref
Rohit Loomba & T Jake Liang. (2007) Treatment of Chronic Hepatitis B. Antiviral Therapy 12:3_suppl, pages 33-41.
Crossref
Crossref
Ji Eun Uhm, Kihyun Kim, Tae Kyu Lim, Byeong-Bae Park, Sarah Park, Yong Sang Hong, Sang Cheol Lee, In Gyu Hwang, Kwang Cheol Koh, Mark H. Lee, Jin Seok Ahn, Won Seog Kim, Chul Won Jung & Won Ki Kang. (2007) Changes in Serologic Markers of Hepatitis B Following Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 13:4, pages 463-468.
Crossref
Crossref
Jin Seok KimJee Sook HahnSun Young ParkYuri KimIn Hae ParkChun Kyon LeeJune-Won CheongSeung Tae LeeYoo Hong Min. (2007) Long-term Outcome after Prophylactic Lamivudine Treatment on Hepatitis B Virus Reactivation in Non-Hodgkin's Lymphoma. Yonsei Medical Journal 48:1, pages 78.
Crossref
Crossref
M. Sandherr, H. Einsele, H. Hebart, C. Kahl, W. Kern, M. Kiehl, G. Massenkeil, O. Penack, X. Schiel, S. Schuettrumpf, A.J. Ullmann & O.A. Cornely. (2006) Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Annals of Oncology 17:7, pages 1051-1059.
Crossref
Crossref
Ming-Shen Dai & Tsu-Yi Chao. (2005) Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?. Breast Cancer Research and Treatment 92:1, pages 95-96.
Crossref
Crossref
Peng-Chan Lin, Say-Bee Poh, Ming-Yang Lee, Liang-Tsai Hsiao, Po-Min Chen & Tzeon-Jye Chiou. (2005) Fatal Fulminant Hepatitis B after Withdrawal of Prophylactic Lamivudine in Hematopoietic Stem Cell Transplantation Patients. International Journal of Hematology 81:4, pages 349-351.
Crossref
Crossref
CHEE-KIN HUI, WING-YAN AU & GEORGE K K LAU. (2004) Preemptive therapy for hepatitis B patients undergoing chemotherapy. Journal of Gastroenterology and Hepatology 19:s7, pages S124-S127.
Crossref
Crossref
George K.K Lau, Harry H.Y Yiu, Daniel Y.T Fong, Hoi-Ching Cheng, Wing-Yan Au, Lydia S.F Lai, Micheal Cheung, Hai-Ying Zhang, Albert Lie, Roger Ngan & Raymond Liang. (2003) Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 125:6, pages 1742-1749.
Crossref
Crossref